Skip to main content
TipRanks
Go Ultimate75% OFF

Tyra Bioscience (TYRA) Stock Statistics & Valuation Metrics

159 Followers

Total Valuation

Tyra Bioscience has a market cap or net worth of $1.38B. The enterprise value is $815.64M.

Market Cap
$1.38B
Enterprise Value
$815.64M

Share Statistics

Tyra Bioscience has 69,082,750 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
69,082,750
Owned by Insiders
25.66%
Owned by Institutions
42.51%

Financial Efficiency

Tyra Bioscience’s return on equity (ROE) is -0.46 and return on invested capital (ROIC) is -50.10%.

Return on Equity (ROE)
-0.46
Return on Assets (ROA)
-0.42
Return on Invested Capital (ROIC)
-50.10%
Return on Capital Employed (ROCE)
-0.50
Revenue Per Employee
0
Profits Per Employee
-1.38M
Employee Count
87
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Tyra Bioscience is -7.59. Tyra Bioscience’s PEG ratio is 0.24.

PE Ratio
-7.59
PS Ratio
0.00
PB Ratio
2.00
Price to FCF
-11.53
Price to Operating Cash Flow
-11.58
PEG Ratio
0.24

Income Statement

In the last 12 months, Tyra Bioscience had revenue of 0 and earned -119.95M in profits. Earnings per share was -2.01.

Revenue
0
Gross Profit
0
Operating Income
-132.76M
Pretax Income
-119.95M
Net Income
-119.95M
EBITDA
-119.40M
Earnings Per Share (EPS)
-2.01

Cash Flow

In the last 12 months, operating cash flow was -119.48M and capital expenditures -301,000, giving a free cash flow of -119.78M billion.

Operating Cash Flow
-119.48M
Free Cash Flow
-119.78M
Free Cash Flow per Share
-1.73

Dividends & Yields

Tyra Bioscience pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-8.67%
Earnings Yield
-12.28%

Stock Price Statistics

Beta
0.90
52-Week Price Change
28.45%
50-Day Moving Average
21.75
200-Day Moving Average
29.43
Relative Strength Index (RSI)
42.73
Average Volume (3m)
841.26K

Important Dates

Tyra Bioscience upcoming earnings date is Mar 24, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 10, 2026
Next Earnings Date
Mar 24, 2027
Ex-Dividend Date
―

Financial Position

Tyra Bioscience as a current ratio of 14.67, with Debt / Equity ratio of 2.24%

Current Ratio
14.67
Quick Ratio
14.67
Debt to Market Cap
0.00
Net Debt to EBITDA
0.60
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, Tyra Bioscience has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Tyra Bioscience EV to EBITDA ratio is -5.38, with an EV/FCF ratio of -7.77.

EV to Sales
0.00
EV to EBITDA
-5.38
EV to Free Cash Flow
-7.77
EV to Operating Cash Flow
-7.79

Balance Sheet

Tyra Bioscience has $700.55M in cash and marketable securities with $5.46M in debt, giving a net cash position of $695.08M billion.

Cash & Marketable Securities
$700.55M
Total Debt
$5.46M
Net Cash
$695.08M
Net Cash Per Share
$10.06
Tangible Book Value Per Share
$10.03

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Tyra Bioscience is $47.78, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
$47.78
Price Target Upside
138.59% Upside
Analyst Consensus
Strong Buy
Analyst Count
10
Revenue Growth Forecast
―
EPS Growth Forecast
-40.04%

Scores

Smart Score
6
AI Score
55